Carl W. Langberg

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

Journal: British journal of cancer

Published: September 12, 2025

Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.

Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.

Journal: European urology open science

Published: May 31, 2024

Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study.

Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study.

Journal: Scientific reports

Published: April 08, 2021

Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review.

Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review.

Journal: Transplantation

Published: March 20, 2021

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 27, 2019

MRI in the Follow-up of Testicular Cancer: Less is More.

MRI in the Follow-up of Testicular Cancer: Less is More.

Journal: Anticancer research

Published: May 03, 2019

Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA.

Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 06, 2018

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 25, 2016

Treatment for stage I-testicular cancer should be assessed individually

Treatment for stage I-testicular cancer should be assessed individually

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 29, 2015

Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.

Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 01, 2015

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 13, 2014

Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4.

Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4.

Journal: Human molecular genetics

Published: May 04, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026